Turn Therapeutics Inc. Common Stock

TTRX · NASDAQ · Healthcare / Biotechnology

9.35USD-0.79 (-7.75%)

Price History

Full chart

Market Stats

Previous Close10.13

Open10.25

Day Range9.28 – 10.28

52-Week Range2.57 – 16.45

Volume92.17K

Market Cap379.29M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.28

Dividend Yield0.00%

50-Day Avg10.58

200-Day Avg5.98

About

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Bradley E. Burnam
Employees2
Headquarters250 N Westlake Blvd, Westlake Village, CA, United States, 91362, USA
Websitehttps://turntherapeutics.com

Leadership

Mr. Bradley E. BurnamFounder, CEO & Director · b. 1980
Mr. Zuraiz ChaudharyInterim CFO, VP of Finance & Chief Accounting Officer · b. 1996
Dr. Neilesh Shailesh Ghodadra M.D.Chief Medical Officer & Director · b. 1981
Mohammed ZubairController
Dr. Stephen M. Hahn FASTRO, M.D.Executive Clinical & Regulatory Lead · b. 1960

Financials

Income Statement

Currency: USD	2023-12-31	2024-12-31	2025-12-31
Total Revenue	0	0	0
Operating Income	-2.31M	-1.80M	-5.86M
EBITDA	-2.25M	-1.72M	-3.14M
Net Income	-2.29M	-1.77M	-3.19M
R&D	7.50K	245.96K	265.57K

Balance Sheet

Currency: USD	2023-12-31	2024-12-31	2025-12-31
Total Assets	2.01M	2.05M	12.16M
Total Liabilities	1.93M	2.23M	7.48M
Total Equity	85.77K	-177.43K	4.69M
Cash	1.18M	872.60K	5.08M
Total Debt	25.16K	121.04K	80.38K
Net Debt	-1.16M	-751.56K	-5.00M

Cash Flow

Currency: USD	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-1.38M	-1.36M	-2.56M
Investing Cash Flow	-44.31K	-99.47K	-152.99K
Financing Cash Flow	500.00K	1.15M	6.92M
Capital Expenditure	44.31K	99.47K	152.99K
Free Cash Flow	-1.42M	-1.46M	-2.72M
FCF to OCF	103.22%	107.31%	105.97%

Earnings

Report Date	Sep 16, 2025	Nov 13, 2025	Mar 31, 2026	May 11, 2026	Aug 12, 2026	Nov 12, 2026
EPS Estimate	0.00	0.00	-	-0.02	-0.02	-0.02
EPS Actual	-0.05	-0.07	0.01	-0.04	-0.07	-
Surprise	-	-	-	-100.00%	-250.00%	-
Timing	-	-	Pre-market	After-hours	After-hours	After-hours

Key Statistics & Ratios

Market Cap379.29M

Enterprise Value406.10M

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.00

Price / Book597.28

EPS-0.28

Book Value0.023

Revenue (TTM)0

Gross Profit (TTM)-1.61M

EBITDA-8.51M

Profit Margin0.00%

Operating Margin0.00%

Return on Equity-686.28%

Return on Assets-50.27%

Shares Outstanding30.37M

Shares Float10.83M

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Ownership Breakdown

Institutions: 3.86%
Insiders: 53.88%
Retail / Other: 42.26%

Top Institutional Holders

Steel Peak Wealth Management LLC
249.46K0.82%
DDFG Inc
107.83K0.36%
Wellington Shields & Co., LLC
65.73K0.22%
Millennium Management LLC
60.55K0.20%
Vanguard Capital Management, LLC
49.45K0.16%
Aaron Wealth Advisors LLC
32.56K0.11%
Tamar Securities, LLC
30.00K0.10%
Citadel Advisors Llc
25.87K0.09%
Brown Brothers Harriman & Co
23.69K0.08%
XTX Topco Ltd
19.73K0.07%
HighTower Advisors, LLC
19.68K0.06%
RVW Wealth, LLC
18.00K0.06%
Geode Capital Management, LLC
17.14K0.06%
Miracle Mile Advisors, INC.
16.00K0.05%
Mccarthy Asset Management Inc
15.02K0.05%
Bank of America Corp
14.12K0.05%
LPL Financial Corp
13.30K0.04%

Top Fund Holders

Vanguard MStar Total Stk Mkt Idx Invest
365.20K1.20%
iShares Micro-Cap ETF
37.41K0.12%
Fidelity Nasdaq Composite Index
18.59K0.06%